Gastroretentive Drug Delivery Systems Outsourcing Market Size, Share, Report Analysis And Forecast 2033

The gastroretentive drug delivery systems outsourcing global market report 2024from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.

 

Gastroretentive Drug Delivery Systems Outsourcing Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.

 

Market Size – The gastroretentive drug delivery systems outsourcing market size has grown strongly in recent years. It will grow from $1.29 billion in 2023 to $1.39 billion in 2024 at a compound annual growth rate (CAGR) of 7.7%.  The growth in the historic period can be attributed to the rising incidence of stomach and small intestine disorders, rising drug delivery systems, rising prevalence of gastric cancer, rise in government initiatives, and increase in the number of hospitals.

 

The gastroretentive drug delivery systems outsourcing market size is expected to see strong growth in the next few years. It will grow to $1.89 billion in 2028 at a compound annual growth rate (CAGR) of 8.0%.  The growth in the forecast period can be attributed to increase in the number of ambulatory centers, the focus on patient compliance and convenience, the rising incidence of chronic diseases, increasing personalized medicine, and the growing aging population. Major trends in the forecast period include advancements in polymer science, formulation technologies, bioadhesive systems, novel polymers, drug release modifiers, the development of gastroretentive dosage forms, the integration of digital health technologies, smart gastroretentive systems, and targeted drug delivery.

 

Order your report now for swift delivery @

https://www.thebusinessresearchcompany.com/report/gastroretentive-drug-delivery-systems-outsourcing-global-market-report

 

Scope Of Gastroretentive Drug Delivery Systems Outsourcing Market

The Business Research Company’s reports encompass a wide range of information, including:

1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.

 

Gastroretentive Drug Delivery Systems Outsourcing Market Overview

Market Drivers -The rising prevalence of gastrointestinal disorders is expected to propel the growth of the gastroretentive drug delivery systems outsourcing market going forward. Gastrointestinal disorders refer to a wide range of diseases affecting the digestive tract, which includes the stomach, liver, gallbladder, intestines, and pancreas. Gastrointestinal disorders are rising due to aging populations, antibiotic use, infectious agents, dietary changes, stress and lifestyle factors, and obesity. Outsourcing gastroretentive drug delivery systems provides pharmaceutical companies with the resources and expertise needed to address the growing burden of gastrointestinal disorders, ultimately improving patient outcomes and quality of life. For instance, according to the International Foundation for Gastrointestinal Disorders (IFFGD), a nonprofit education and research organization, it’s estimated that 5–10% of the global population and 25–45 million people in the U.S. have Irritable bowel syndrome (IBS), a common functional gastrointestinal disorder, which accounts for 20–40% of gastroenterologist visits, significantly impacting individuals and healthcare resources. Therefore, the rising prevalence of gastrointestinal disorders is driving the gastroretentive drug delivery systems outsourcing market.

 

Market Trends – Major companies operating in the gastroretentive drug delivery systems outsourcing market are focused on developing innovative products, such as proton pump inhibitors, to enhance drug delivery efficiency and patient convenience. Proton pump inhibitors (PPIs) are a class of medications commonly used to treat conditions related to excessive stomach acid production. For instance, in March 2021, Xiromed LLC, a US-based pharmaceutical company, launched Omeprazole Delayed Release Capsules, 20mg, a generic version of Prilosec. Prilosec (omeprazole) is a proton pump inhibitor medication used to treat conditions caused by excess stomach acid production.  Omeprazole Delayed-Release Capsules offer patients a reliable and visually recognizable dosage form for Omeprazole, a proton pump inhibitor used to treat various gastrointestinal conditions. The specific color and coding of the capsules enhance patient adherence and medication management, ensuring accurate dosing and treatment efficacy.

 

The gastroretentive drug delivery systems outsourcing market covered in this report is segmented –

1) By Type: Floating Systems, Bioadhesive Systems, Other Types

2) By Dosage Form: Tablets, Liquid, Microspheres, Capsule, Other Dosage Forms

3) By Application: Gastroesophageal Reflux Disease (GERD), Neurological Disorders, Other Applications

4) By End User: Pharmaceutical Companies, Contract Research Organizations (CROs), Other End Users

 

Get an inside scoop of the gastroretentive drug delivery systems outsourcing market, Request now for Sample Report @

https://www.thebusinessresearchcompany.com/sample.aspx?id=15813&type=smp

 

Regional Insights – North America was the largest region in the gastroretentive drug delivery systems outsourcing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastroretentive drug delivery systems outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

 

Key Companies – Major companies operating in the gastroretentive drug delivery systems outsourcing market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Sanofi S.A., AstraZeneca plc, Novartis AG, GlaxoSmithKline plc, Evonik Industries AG, Alcon Inc., SGS SA, Lonza Group AG, FMC Corporation, Sun Pharmaceutical Industries Ltd., Catalent Inc., AptarGroup Inc., Cadila Pharmaceuticals, Ashland Global Holdings Inc, Lupin Limited, Torrent Pharmaceuticals Ltd., Evotec SE, Colorcon Inc., Ranbaxy Laboratories Limited, Quotient Sciences Limited, Aenova Group, Vectura Group Ltd., Assertio Therapeutics Inc., Coating Place Inc., Xiromed LLC, SPI Pharma Inc.

 

Table of Contents

1. Executive Summary
2. Gastroretentive Drug Delivery Systems Outsourcing Market Characteristics
3. Gastroretentive Drug Delivery Systems Outsourcing Market Trends And Strategies
4. Gastroretentive Drug Delivery Systems Outsourcing Market – Macro Economic Scenario
5. Global Gastroretentive Drug Delivery Systems Outsourcing Market Size and Growth

………….

34. Key Mergers And Acquisitions In The Gastroretentive Drug Delivery Systems Outsourcing Market
35. Gastroretentive Drug Delivery Systems Outsourcing Market Future Outlook and Potential Analysis
36. Appendix

 

Read Related Reports:

https://goodprnews.com/starter-credit-cards-market-trends-2/

https://topprnews.com/feed-micronutrients-market-size/

 

Learn About Us:

The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

 

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

 

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model